UNAIDS Global HIV & AIDS statistics — 2020 fact sheet. https://www.unaids.org/en/resources/fact-sheet.
Wolinsky, 1992, Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants, Science, 255, 1134, 10.1126/science.1546316
Mahy, 2010, What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs, Sex. Transm. Infect., 86, ii48, 10.1136/sti.2010.045989
Dorenbaum, 2002, Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial, JAMA, 288, 189, 10.1001/jama.288.2.189
Bailey, 2018, HIV treatment in pregnancy, Lancet HIV, 5, e457, 10.1016/S2352-3018(18)30059-6
Kellerman, 2010, HIV testing for children in resource-limited settings: what are we waiting for?, PLoS Med., 7, e1000285, 10.1371/journal.pmed.1000285
Tang, 2010, HIV and pregnancy in resource-poor settings, Rev. Obstet. Gynecol., 3, 66
Permar, 2015, Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission, J. Clin. Invest., 125, 2702, 10.1172/JCI81593
Fouda, 2018, The impact of IgG transplacental transfer on early life immunity, Immunohorizons, 2, 14, 10.4049/immunohorizons.1700057
Martinez, 2017, Maternal binding and neutralizing IgG responses targeting the C-terminal region of the V3 loop are predictive of reduced peripartum HIV-1 transmission risk, J. Virol., 91, e02422-16, 10.1128/JVI.02422-16
Albrecht, 2020, Vertically transferred immunity in neonates: mothers, mechanisms and mediators, Front. Immunol., 11, 555, 10.3389/fimmu.2020.00555
Martinez, 2019, Fc characteristics mediate selective placental transfer of IgG in HIV-infected women, Cell, 178, 190, 10.1016/j.cell.2019.05.046
Wilcox, 2017, Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy, Front. Immunol., 8, 1294, 10.3389/fimmu.2017.01294
Palmeira, 2012, IgG placental transfer in healthy and pathological pregnancies, Clin. Dev. Immunol., 2012, 985646, 10.1155/2012/985646
Martinez, 2020, Maternal broadly neutralizing antibodies can select for neutralization-resistant, infant-transmitted/founder HIV variants, MBio, 11, e00176-20, 10.1128/mBio.00176-20
Moody, 2015, Strain-specific V3 and CD4 binding site autologous HIV-1 neutralizing antibodies select neutralization-resistant viruses, Cell Host Microbe, 18, 354, 10.1016/j.chom.2015.08.006
Kumar, 2018, Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma, PLoS Pathog., 14, e1006944, 10.1371/journal.ppat.1006944
Wilcox, 2018, Beyond passive immunity: is there priming of the fetal immune system following vaccination in pregnancy and what are the potential clinical implications?, Front. Immunol., 9, 1548, 10.3389/fimmu.2018.01548
Frascoli, 2018, Alloreactive fetal T cells promote uterine contractility in preterm labor via IFN-γ and TNF-α, Sci. Transl. Med., 10, eaan2263, 10.1126/scitranslmed.aan2263
Agrawal, 2012, Intrauterine infection and preterm labor, Semin. Fetal Neonatal Med., 17, 12, 10.1016/j.siny.2011.09.001
Neta, 2010, Umbilical cord serum cytokine levels and risks of small-for-gestational-age and preterm birth, Am. J. Epidemiol., 171, 859, 10.1093/aje/kwq028
McGovern, 2017, Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2, Nature, 546, 662, 10.1038/nature22795
Dauby, 2020, Fetal infections: immune response to infections during fetal life, 215
Bunders, 2014, Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1, Sci. Rep., 4, 6690, 10.1038/srep06690
Giorgi, 2010, Estimating time since infection in early homogeneous HIV-1 samples using a poisson model, BMC Bioinformatics, 11, 532, 10.1186/1471-2105-11-532
Suchard, 2018, Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10, Virus Evol., 4, vey016, 10.1093/ve/vey016
Song, 2018, Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection, Nat. Commun., 9, 1928, 10.1038/s41467-018-04217-5
Giorgi, 2020, Estimating the timing of early simian-human immunodeficiency virus infections: a comparison between Poisson Fitter and BEAST, MBio, 11, e00324-20, 10.1128/mBio.00324-20
Murrell, 2012, Detecting individual sites subject to episodic diversifying selection, PLoS Genet., 8, e1002764, 10.1371/journal.pgen.1002764
Zhou, 2007, Structural definition of a conserved neutralization epitope on HIV-1 gp120, Nature, 445, 732, 10.1038/nature05580
Moore, 2012, Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape, Nat. Med., 18, 1688, 10.1038/nm.2985
Pejchal, 2010, Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1, Proc. Natl. Acad. Sci. USA, 107, 11483, 10.1073/pnas.1004600107
Kwong, 2018, HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure, Immunity, 48, 855, 10.1016/j.immuni.2018.04.029
Sok, 2018, Recent progress in broadly neutralizing antibodies to HIV, Nat. Immunol., 19, 1179, 10.1038/s41590-018-0235-7
Schatten, 2007
Codaccioni, 2019, Placental transfer of xenobiotics in pregnancy physiologically-based pharmacokinetic models: structure and data, Comput. Toxicol., 12, 100111, 10.1016/j.comtox.2019.100111
Chatuphonprasert, 2018, Physiology and pathophysiology of steroid biosynthesis, transport and metabolism in the human placenta, Front. Pharmacol., 9, 1027, 10.3389/fphar.2018.01027
Underwood, 2005, Amniotic fluid: not just fetal urine anymore, J. Perinatol., 25, 341, 10.1038/sj.jp.7211290
Mold, 2008, Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero, Science, 322, 1562, 10.1126/science.1164511
Claas, 1988, Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life, Science, 241, 1815, 10.1126/science.3051377
Aagaard, 2014, The placenta harbors a unique microbiome, Sci. Transl. Med., 6, 237ra65
Campbell, 2015, Mechanisms of allergic disease - environmental and genetic determinants for the development of allergy, Clin. Exp. Allergy, 45, 844, 10.1111/cea.12531
Berry, 1992, Circulating lymphocyte subsets in second- and third-trimester fetuses: comparison with newborns and adults, Am. J. Obstet. Gynecol., 167, 895, 10.1016/S0002-9378(12)80008-1
Rechavi, 2015, Timely and spatially regulated maturation of B and T cell repertoire during human fetal development, Sci. Transl. Med., 7, 276ra25, 10.1126/scitranslmed.aaa0072
Douglas, 2017, The role of maternal HIV envelope-specific antibodies and mother-to-child transmission risk, Front. Immunol., 8, 1091, 10.3389/fimmu.2017.01091
Thobakgale, 2007, Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants, J. Virol., 81, 12775, 10.1128/JVI.00624-07
Moody, 2016, Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies, Sci. Immunol., 1, aag0851, 10.1126/sciimmunol.aag0851
Keele, 2008, Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection, Proc. Natl. Acad. Sci. USA, 105, 7552, 10.1073/pnas.0802203105
2009
Anderson, 1997, The placental barrier to maternal HIV infection, Obstet. Gynecol. Clin. North Am., 24, 797, 10.1016/S0889-8545(05)70345-4
Gouy, 2010, SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building, Mol. Biol. Evol., 27, 221, 10.1093/molbev/msp259
Nei, 1986, Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions, Mol. Biol. Evol., 3, 418
Montefiori, 2009, Measuring HIV neutralization in a luciferase reporter gene assay, Methods Mol. Biol., 485, 395, 10.1007/978-1-59745-170-3_26